ANI Total Current Assets from 2010 to 2025

ANIP Stock  USD 58.92  0.27  0.46%   
ANI Pharmaceuticals Total Current Assets yearly trend continues to be relatively stable with very little volatility. Total Current Assets are likely to grow to about 627.7 M this year. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2000-03-31
Previous Quarter
555.2 M
Current Value
521.3 M
Quarterly Volatility
137.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ANI Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ANI Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 72.2 M, Interest Expense of 32.5 M or Selling General Administrative of 181.6 M, as well as many indicators such as Price To Sales Ratio of 2.23, Dividend Yield of 0.0012 or PTB Ratio of 2.37. ANI financial statements analysis is a perfect complement when working with ANI Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of ANI Pharmaceuticals Correlation against competitors.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Latest ANI Pharmaceuticals' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of ANI Pharmaceuticals over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. ANI Pharmaceuticals' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ANI Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
187.170.321.344.519.597.627.-9%89%7%51%15%5%100%
       Timeline  

ANI Total Current Assets Regression Statistics

Arithmetic Mean229,794,766
Geometric Mean132,707,800
Coefficient Of Variation86.90
Mean Deviation157,793,049
Median187,695,000
Standard Deviation199,685,833
Sample Variance39874.4T
Range624.8M
R-Value0.90
Mean Square Error8408.8T
R-Squared0.80
Slope37,588,834
Total Sum of Squares598116.5T

ANI Total Current Assets History

2025627.7 M
2024597.8 M
2023519.8 M
2022344.3 M
2021321.8 M
2020170.3 M
2019187.7 M

About ANI Pharmaceuticals Financial Statements

ANI Pharmaceuticals shareholders use historical fundamental indicators, such as Total Current Assets, to determine how well the company is positioned to perform in the future. Although ANI Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in ANI Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on ANI Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets597.8 M627.7 M

Additional Tools for ANI Stock Analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.